United States · FDA National Drug Code directory
Risperidone
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 59746-020_90b80768-87f7-4fb1-8142-909dba9555e2
- Product NDC
- 59746-020
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- Risperidone
- Labeler
- Jubilant Cadista Pharmacuticals Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20111104
- Source listing expiry
- 20261231
Source-listed ingredients
- RISPERIDONE — 1 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 7 BLISTER PACK in 1 CARTON (59746-020-22) / 4 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 59746-020-22
- 3 BLISTER PACK in 1 CARTON (59746-020-32) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 59746-020-32
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →